| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.33 | 2e-11 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.31 | 3e-11 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.34 | 4e-09 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.15 | 0.0009 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.14 | 0.008 |